NCT06467409View on ClinicalTrials.gov

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Pain, Postoperative
Interventions
DRUG

Placebo

patient-controlled analgesia(PCA) administration

DRUG

morphine hydrochloride injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

Trial Locations (1)

Unknown

RECRUITING

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY